Department of Surgical Sciences
Telephone: +39 070 609 2319
Personal webpage: here
Main areas of expertise: Retinal diseases, Vitreous-retina surgery, maculopathies, diabetic retinopathy, Multimodal imaging related to retinal diseases.
Prof. Enrico Peiretti dedicated over twenty years of his work life to ophthalmic research. His four-year residency in Ophthalmology has been carried out at the University of Cagliari, during which he spent six months for an international fellowship program at the “Fondation A. de Rothschild” in Paris under the supervision of Prof. S. Morax.
Following his residency program, he was granted an international fellowship at the LuEsther T. Mertz Retina Research Institute; Manhattan Eye, Ear and Throat Hospital, New York with Dr Lawrence Yannuzzi. Since then, his practice and his research have been mainly focused on medical retina pathologies.
In 2010 dr. Peiretti become an Assistant Professor at the Eye-Clinic, University of Cagliari, and in 2013 he completed a Vitreous-Retina Surgery fellowship at the Academisch Medisch Centrum (AMC) in Amsterdam, Netherlands, where he is a certificate ophthalmologist in the Netherlands BIG register.
In 2019 dr. Peiretti became an Associate Professor at the University of Cagliari and he currently is the head of the Retina Unit at the eye Clinic, University of Cagliari, Italy, and the most proficient Vitreous-Retina Surgeon at the surgical department of Cagliari University.
Dr. Peiretti has authored nearly 100 scientific articles in peer-reviewed international journals and book chapters and attended at many international meetings and lectured worldwide about retina and vitreous diseases. He served as PI for many multicentric clinical trials, and as a collaborator in several national and international projects in the retina field. He is a member of the editorial board of the Journal of Ophthalmology and serves as a reviewer for numerous ophthalmologic journals mainly focusing on medical and surgical retina pathologies. Dr Peiretti developed two international patents and he is a medical advisor for several pharmaceutical companies related to the ophthalmic field.